Literature DB >> 19898444

The gold rush for induced pluripotent stem cells.

Sarah Webb.   

Abstract

Mesh：

Year:  2009        PMID： 19898444     DOI： 10.1038/nbt1109-977

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

2.  Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Authors:  John T Dimos; Kit T Rodolfa; Kathy K Niakan; Laurin M Weisenthal; Hiroshi Mitsumoto; Wendy Chung; Gist F Croft; Genevieve Saphier; Rudy Leibel; Robin Goland; Hynek Wichterle; Christopher E Henderson; Kevin Eggan
Journal:  Science       Date:  2008-07-31       Impact factor: 47.728

3.  A chemical platform for improved induction of human iPSCs.

Authors:  Tongxiang Lin; Rajesh Ambasudhan; Xu Yuan; Wenlin Li; Simon Hilcove; Ramzey Abujarour; Xiangyi Lin; Heung Sik Hahm; Ergeng Hao; Alberto Hayek; Sheng Ding
Journal:  Nat Methods       Date:  2009-10-18       Impact factor: 28.547

4.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

5.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

6.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Authors:  Dohoon Kim; Chun-Hyung Kim; Jung-Il Moon; Young-Gie Chung; Mi-Yoon Chang; Baek-Soo Han; Sanghyeok Ko; Eungi Yang; Kwang Yul Cha; Robert Lanza; Kwang-Soo Kim
Journal:  Cell Stem Cell       Date:  2009-05-28       Impact factor: 24.633

7.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962
  7 in total
  5 in total

Review 1.  Regenerative nanomedicines: an emerging investment prospective?

Authors:  Catherine Prescott
Journal:  J R Soc Interface       Date:  2010-09-08       Impact factor: 4.118

2.  Burgeoning stem cell product market lures major suppliers.

Authors:  Sarah Webb
Journal:  Nat Biotechnol       Date:  2010-06       Impact factor: 54.908

3.  The global intellectual property landscape of induced pluripotent stem cell technologies.

Authors:  MacKenna Roberts; Ivan B Wall; Ian Bingham; Dominic Icely; Brock Reeve; Kim Bure; Anna French; David A Brindley
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

4.  Quality metrics for stem cell-derived cardiac myocytes.

Authors:  Sean P Sheehy; Francesco Pasqualini; Anna Grosberg; Sung Jin Park; Yvonne Aratyn-Schaus; Kevin Kit Parker
Journal:  Stem Cell Reports       Date:  2014-03-06       Impact factor: 7.765

Review 5.  LULL(ed) into complacency: a perspective on licenses and stem cell translational science.

Authors:  Mahendra S Rao
Journal:  Stem Cell Res Ther       Date:  2013-08-14       Impact factor: 6.832
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.